List of articles with "FDA"

Sobi's NASP Update

Sobi's NASP Update

USA FDA Stockholm Sobi NASP
Sobi's FDA Response

Sobi's FDA Response

USA FDA Stockholm Sobi NASP
Aardvark Therapeutics Drama

Aardvark Therapeutics Drama

United States San Francisco FDA Aardvark Therapeutics ARD-101
Aidoc's AI Radiology Progress

Aidoc's AI Radiology Progress

United States AI New York FDA Aidoc
UpDoc's AI Platform

UpDoc's AI Platform

United States FDA Palo Alto AI Platform UpDoc
FDA Pharmaceutical Warnings

FDA Pharmaceutical Warnings

United States Raleigh FDA Compliance pharmaceutical
MIT Acquires Cellmyx

MIT Acquires Cellmyx

United States Irvine FDA Micro Imaging Technology Cellmyx
CenExel in Psychedelics

CenExel in Psychedelics

United States FDA psychedelics Draper CenExel
TOBY's Alzheimer's Test

TOBY's Alzheimer's Test

USA Austin FDA Alzheimer's Disease TOBY Test
FDA's Revolving Door Issues

FDA's Revolving Door Issues

United States Los Angeles FDA pharmaceutical lawsuits
ImmunityBio Under Fire

ImmunityBio Under Fire

USA San Francisco FDA ImmunityBio IBRX
Aardvark Investor Concerns

Aardvark Investor Concerns

USA San Francisco FDA Aardvark Therapeutics ARD-101
Viatris FDA Acceptance

Viatris FDA Acceptance

United States FDA Pittsburgh Viatris Meloxicam
CytoSorbents Q1 2026 Update

CytoSorbents Q1 2026 Update

USA FDA Princeton CytoSorbents DrugSorb-ATR
Investigation for PepGen

Investigation for PepGen

United States New York FDA Pomerantz Law PepGen
FDA Approves New E-Cigarettes

FDA Approves New E-Cigarettes

Washington FDA E-cigarettes Youth Smoking
FDA Flavored E-Cigs

FDA Flavored E-Cigs

United States Washington, D.C. FDA Truth Initiative EX Program
TransCelerate and FDA Collaboration

TransCelerate and FDA Collaboration

United States Philadelphia FDA Clinical Trials TransCelerate
PepGen Investors Alert

PepGen Investors Alert

United States New York FDA Pomerantz LLP PepGen
Medtech Regulatory Changes

Medtech Regulatory Changes

Canada Vancouver MedTech FDA Ventripoint
Revolutionizing Trials

Revolutionizing Trials

USA Washington FDA Clinical Trials Paradigm Health
AI in QMSR Transition

AI in QMSR Transition

None AI FDA QMSR
Humacyte Investigation

Humacyte Investigation

United States Humacyte FDA New Orleans Kahn Swick
AbbVie Updates on TrenibotE

AbbVie Updates on TrenibotE

United States FDA AbbVie North Chicago TrenibotulinumtoxinE
Ceglu™ FDA Registration

Ceglu™ FDA Registration

Japan FDA Tokyo Sekisui Chemical Ceglu™
Corcept Investor Alert

Corcept Investor Alert

USA Class Action San Francisco FDA Corcept Therapeutics
Enhanced Supports FDA Guidance

Enhanced Supports FDA Guidance

United States New York FDA peptides Enhanced
FDA Reclassification Update

FDA Reclassification Update

FDA Norway Oslo Photocure ASA Diagnostic Tools
uniQure Investigation

uniQure Investigation

USA San Francisco FDA Hagens Berman uniQure
IKE Tech and FDA Partnership

IKE Tech and FDA Partnership

USA Los Angeles FDA IKE Tech ENDS
Mifepristone Court Ruling

Mifepristone Court Ruling

United States Washington FDA Family Research Council Mifepristone
uniQure Investigation Updates

uniQure Investigation Updates

USA San Francisco FDA Hagens Berman uniQure
uniQure Investigation Update

uniQure Investigation Update

USA San Francisco FDA Hagens Berman uniQure
ImmunityBio Legal Troubles

ImmunityBio Legal Troubles

United States San Francisco FDA ImmunityBio Anktiva
FDA Accelerates Gene Editing

FDA Accelerates Gene Editing

United States Philadelphia FDA Gene Editing Urea Cycle
ImmunityBio Class Action

ImmunityBio Class Action

USA San Francisco FDA ImmunityBio Anktiva
Stealth AXiS™ Launch

Stealth AXiS™ Launch

USA FDA Medtronic Galway Stealth AXiS™
FDA Conflict of Interest Call

FDA Conflict of Interest Call

United States Chicago FDA Sarfaraz Niazi conflict of interest
uniQure Investigation Update

uniQure Investigation Update

USA San Francisco FDA Securities Class Action uniQure
FDA Costs & Rejections

FDA Costs & Rejections

USA Washington FDA TPA Drug Approvals
Pomerantz Investigates PepGen

Pomerantz Investigates PepGen

USA New York FDA Pomerantz Law Firm PepGen Inc.
FDA Supports DTE Access

FDA Supports DTE Access

United States Alpharetta FDA Acella Pharmaceuticals NP Thyroid
Investigation into Disc Medicine

Investigation into Disc Medicine

USA New York FDA Iron Disc Medicine
FusionEdge Enhances FDA Systems

FusionEdge Enhances FDA Systems

USA FDA Sterling FusionEdge TechSur Solutions
Vanda Pushes FDA Reform

Vanda Pushes FDA Reform

United States Washington FDA Vanda Pharmaceuticals animal testing
Investigation into PepGen

Investigation into PepGen

None FDA Pomerantz LLP PepGen Inc.
Armata Pharmaceuticals Update

Armata Pharmaceuticals Update

United States Los Angeles FDA Armata Pharmaceuticals AP-SA02
uniQure Investigation Update

uniQure Investigation Update

FDA Hagens Berman uniQure
Disc Medicine's Stock Drop

Disc Medicine's Stock Drop

United States New York FDA Disc Medicine Bitopertin
Ispire and FDA's ENDS Guidance

Ispire and FDA's ENDS Guidance

United States Los Angeles FDA Ispire Technology flavored ENDS

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.